-
1
-
-
18344419026
-
Anti-TNFα therapy for ankylosing spondylitis: International experience
-
Braun J, Sieper J, et al. Anti-TNFα therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 2002;61 (Suppl):51-60.
-
(2002)
Ann Rheum Dis
, vol.61
, Issue.SUPPL.
, pp. 51-60
-
-
Braun, J.1
Sieper, J.2
-
2
-
-
0033574147
-
Etanercept therapy in rheumatoid arthritis. A randomised controlled trial
-
Moreland LW, Schiff MH, Baumgartner SW, et al. Etanercept therapy in rheumatoid arthritis. A randomised controlled trial. Ann Intern Med 1999;130:478-86.
-
(1999)
Ann Intern Med
, vol.130
, pp. 478-486
-
-
Moreland, L.W.1
Schiff, M.H.2
Baumgartner, S.W.3
-
3
-
-
0037007683
-
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha
-
Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
-
(2002)
N Engl J Med
, vol.346
, pp. 1349-1356
-
-
Gorman, J.D.1
Sack, K.E.2
Davis J.C., Jr.3
-
4
-
-
0036251259
-
Safety and efficacy of disease-modifying anti-rheumatic agents: Focus on the benefits and risks of etanercept
-
Fleischmann R, Iqbal I, Nandeshwar P, et al. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. Drug Safety 2002;25:173-97.
-
(2002)
Drug Safety
, vol.25
, pp. 173-197
-
-
Fleischmann, R.1
Iqbal, I.2
Nandeshwar, P.3
-
5
-
-
0036185035
-
Development of rheumatoid nodules during anti-TNFα therapy with etanercept
-
Kekow J, Welte T, Kellner U, et al. Development of rheumatoid nodules during anti-TNFα therapy with etanercept. Arthritis Rheum 2002;46:843-4.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 843-844
-
-
Kekow, J.1
Welte, T.2
Kellner, U.3
-
7
-
-
0029561997
-
Systemic anti-tumour necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat
-
De Vos AF, Van Haren MAC, Verhagen C, et al. Systemic anti-tumour necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat. Exp Eye Res 1995;61:667-75.
-
(1995)
Exp Eye Res
, vol.61
, pp. 667-675
-
-
De Vos, A.F.1
Van Haren, M.A.C.2
Verhagen, C.3
-
8
-
-
0034974633
-
Etanercept therapy in children with treatment-resistant uveitis
-
Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum 2001;44:1411-5.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1411-1415
-
-
Reiff, A.1
Takei, S.2
Sadeghi, S.3
-
9
-
-
0034796250
-
Differential efficacy of tumour necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease
-
Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumour necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Care Res 2001;45:252-7.
-
(2001)
Arthritis Care Res
, vol.45
, pp. 252-257
-
-
Smith, J.R.1
Levinson, R.D.2
Holland, G.N.3
-
10
-
-
0030769165
-
The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire
-
Cope A, Ettinger R, et al. The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 1997;148:307-12.
-
(1997)
Res Immunol
, vol.148
, pp. 307-312
-
-
Cope, A.1
Ettinger, R.2
-
11
-
-
0034609968
-
T-cell function and migration: Two sides of the same coin
-
Von Andrian UH, Mackay CR. T-cell function and migration: two sides of the same coin. N Engl J Med 2000;343:1020-34.
-
(2000)
N Engl J Med
, vol.343
, pp. 1020-1034
-
-
Von Andrian, U.H.1
Mackay, C.R.2
|